The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of Akt inhibition with change in immunophenotype of tumor microenvironment (TME) in breast cancer (BC).
 
Douglas Kanter Marks
Consulting or Advisory Role - Michael J. Hennessy; Takeda
 
Robyn Denise Gartrell
Consulting or Advisory Role - Takeda
Patents, Royalties, Other Intellectual Property - Amgen; Amgen (Inst); Columbia University
Travel, Accommodations, Expenses - Perkin Elmer
 
Margueritta El Asmar
No Relationships to Disclose
 
Shuobo Boboila
No Relationships to Disclose
 
Thomas D Hart
No Relationships to Disclose
 
Camden L Esancy
No Relationships to Disclose
 
Yan Lu
No Relationships to Disclose
 
Hanina Hibshoosh
No Relationships to Disclose
 
Eileen Connolly
Employment - Celgene (I)
Stock and Other Ownership Interests - Celgene; Celgene (I)
 
Kevin Kalinsky
Stock and Other Ownership Interests - Novartis (I)
Consulting or Advisory Role - Amgen; bioTheranostics; Eisai; Lilly; Novartis; pfizer
 
Yvonne M. Saenger
Research Funding - Amgen; Intensity Therapeutics
Patents, Royalties, Other Intellectual Property - Amgen; Amgen (Inst); OmniSeq; OmniSeq (Inst)
Travel, Accommodations, Expenses - Rockpointe CME